Editorial: Contemporary applications of machine learning and artificial intelligence for the management of heart
Andre Rodrigues Duraes1, Mansueto Gomes-Neto1, Edimar Alcides Bocchi2
1Federal University of Bahia (UFBA), Salvador, Brazil.
Insights
Machine learning and artificial intelligence (AI) are revolutionizing heart failure (HF) management. These advanced technologies offer new ways to diagnose, stratify, and predict outcomes for patients with HF.
Area of Science:
- Cardiovascular Medicine
- Biomedical Data Science
- Computational Biology
Background:
- Heart failure (HF) presents significant clinical and economic challenges.
- Contemporary management of HF requires innovative approaches for diagnosis, risk stratification, and patient monitoring.
Discussion:
- This editorial reviews four studies applying machine learning (ML) and artificial intelligence (AI) to HF.
- The reviewed articles explore AI's role in early diagnosis via novel biomarkers, disease stratification using transcriptomics, understanding apoptotic pathways, and predictive telemonitoring.
- Integration of these data-driven technologies into routine clinical practice is discussed, highlighting potential benefits and challenges.
Key Insights:
- AI and ML enable early diagnosis of heart failure using novel biomarkers.
- Transcriptomics combined with AI aids in accurate disease stratification.
- Real-time AI models enhance predictive telemonitoring for preventing decompensation.
- Data-driven approaches promise personalized care strategies for HF patients.
Outlook:
- The transformative potential of AI and ML in personalizing HF care is significant.
- Future integration of these technologies could lead to improved patient outcomes and reduced healthcare costs.
- Addressing the challenges in implementation is crucial for realizing the full benefits of AI in HF management.
Abstract:
Heart failure (HF) is a complex syndrome with substantial clinical and economic impact. This editorial highlights four original articles published in Frontiers in Cardiovascular Medicine that showcase contemporary applications of machine learning and artificial intelligence (AI) in HF management. These studies address early diagnosis through novel biomarkers, disease stratification based on transcriptomics, mechanistic insight into apoptotic pathways, and predictive telemonitoring using real-time AI models. Collectively, these contributions exemplify the transformative potential of data-driven technologies in personalizing care and preventing decompensation in HF. We discuss both the promise and challenges of integrating these tools into routine.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Cardiomyopathy V: Interprofessional Care


